Alnylam Pharmaceuticals, Inc.ALNY

Where ALNY's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$264.50-2.90 (-1.08%)Previous close
NASDAQHealthcare

ALNY Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
ALNY Net Debt / EBITDA historyALNY Net Debt / EBITDA from Sep 2023 to Jun 2026: low -13.93, high 13.99, latest -0.38.-16.17-8.070.038.1216.22Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med -1.07

ALNY Net Debt / EBITDA by year

Yearly range of ALNY’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from -13.9 to 14.0, averaging -0.3.

ALNY Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026-0.5-0.4-0.4-0.4
2025-1.8-1.1-0.6-0.6
2024-13.9-0.814.0-1.8
2023-7.2-2.4-0.7-7.2
2022-0.7-0.5-0.3-0.5
2021-0.30.00.5-0.3
2020-0.00.20.3-0.0
20190.30.60.90.3
20180.40.50.70.5
20170.10.51.31.3
20160.00.10.10.1

Get notified when ALNY Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.